Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (33)
Anjali Geethadevi, Kapilesh Jadhav, Gaurav Kumar & Deepak Parashar. (2020) scFv6.C4 DNA vaccine with fragment C of tetanus toxin increases protective immunity against CEA-expressing tumor. Gene Therapy 28:6, pages 287-289.
Crossref
Crossref
Shing Yi Pan, Yvonne Cashinn Chia, Hui Rong Yee, Angelina Ying Fang Cheng, Clarice Evey Anjum, Yenny Kenisi, Mike KS Chan & Michelle BF Wong. (2021) Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases. Future Science OA 7:2.
Crossref
Crossref
Christin Eger, Nikolai Siebert, Diana Seidel, Maxi Zumpe, Madlen Jüttner, Sven Brandt, Hans-Peter Müller & Holger N. Lode. (2016) Generation and Characterization of a Human/Mouse Chimeric GD2-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma. PLOS ONE 11:3, pages e0150479.
Crossref
Crossref
Alejandro López-Requena, Oscar R. Burrone & Rolando Pérez. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
407
434
.
Qi Zhao, Pui-Fan Wong, Susanna S. T. Lee, Shui-On Leung, Wing-Tai Cheung & Jun-Zhi Wang. (2014) Generation of Anti-Idiotype scFv for Pharmacokinetic Measurement in Lymphoma Patients Treated with Chimera Anti-CD22 Antibody SM03. PLoS ONE 9:5, pages e96697.
Crossref
Crossref
Malaya Bhattacharya-Chatterjee, Sunil K. Chatterjee, Asim Saha & Kenneth A. Foon. 2017. Encyclopedia of Cancer. Encyclopedia of Cancer
771
777
.
Malaya Bhattacharya-Chatterjee, Sunil K. Chatterjee, Asim Saha & Kenneth A. Foon. 2016. Encyclopedia of Cancer. Encyclopedia of Cancer
1
6
.
Shanju Sankar, Sangeetha K. Nayanar & Satheesan Balasubramanian. (2013) Current Trends in Cancer Vaccines - a Bioinformatics Perspective. Asian Pacific Journal of Cancer Prevention 14:7, pages 4041-4047.
Crossref
Crossref
Holger N. Lode, Manuela Schmidt, Diana Seidel, Nicole Huebener, Diana Brackrock, Matthias Bleeke, Daniel Reker, Sven Brandt, Hans-Peter Mueller, Christiane Helm & Nikolai Siebert. (2013) Vaccination with anti-idiotype antibody ganglidiomab mediates a GD2-specific anti-neuroblastoma immune response. Cancer Immunology, Immunotherapy 62:6, pages 999-1010.
Crossref
Crossref
Paul SabbatiniPhilipp HarterGiovanni ScambiaJalid SehouliWerner MeierPauline WimbergerKlaus H. BaumannChristian KurzederBarbara SchmalfeldtDavid CibulaMariusz BidzinskiAntonio CasadoAndrea MartoniNicoletta ColomboRobert W. HollowayLuigi SelvaggiAndrew LiJose del CampoKarel CwiertkaTamas PinterJan B. VermorkenEric Pujade-LauraineSimona ScartoniMonica BertolottiCecilia SimonelliAngela CapriatiCarlo Alberto MaggiJonathan S. BerekJacobus Pfisterer. (2013) Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study. Journal of Clinical Oncology 31:12, pages 1554-1561.
Crossref
Crossref
Francesco Pappalardo, Ferdinando Chiacchio & Santo Motta. (2013) Cancer Vaccines: State of the Art of the Computational Modeling Approaches. BioMed Research International 2013, pages 1-6.
Crossref
Crossref
Francesco Pappalardo & Santo Motta. (2012) Modeling Cancer Vaccines. Modeling Cancer Vaccines.
György BerencsiIIIIII & Katalin Ördög. 2012. Maternal Fetal Transmission of Human Viruses and their Influence on Tumorigenesis. Maternal Fetal Transmission of Human Viruses and their Influence on Tumorigenesis
223
247
.
Rachel N Grisham, Jonathan Berek, Jacobus Pfisterer & Paul Sabbatini. (2011) Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer. Immunotherapy 3:2, pages 153-162.
Crossref
Crossref
. 2011. Encyclopedia of Cancer. Encyclopedia of Cancer
630
635
.
Takuya YAMASHITA, Naoki UTOGUCHI, Ryo SUZUKI, Kazuya NAGANO, Shin-ichi TSUNODA, Yasuo TSUTSUMI & Kazuo MARUYAMA. (2010) Development of Anti-tumor Blood Vessel Antibodies by Phage Display Methodファージディスプレイ法を用いた腫瘍組織血管抗体の創製. YAKUGAKU ZASSHI 130:4, pages 479-485.
Crossref
Crossref
Asim Saha & Sunil K. Chatterjee. (2010) Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2/neu induced protective antitumor immunity in two lines of Her-2/neu transgenic mice. Cellular Immunology 263:1, pages 9-21.
Crossref
Crossref
Francesco Pappalardo, Marzio Pennisi, Filippo Castiglione & Santo Motta. (2010) Vaccine protocols optimization: In silico experiences. Biotechnology Advances 28:1, pages 82-93.
Crossref
Crossref
Nidia Alvarez-Rueda, Maha Zohra Ladjemi, Ghislaine Béhar, Stéphanie Corgnac, Martine Pugnière, Françoise Roquet, Caroline Bascoul-Mollevi, Daniel Baty, André Pèlegrin & Isabelle Navarro-Teulon. (2009) A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy. Vaccine 27:35, pages 4826-4833.
Crossref
Crossref
Malaya Bhattacharya‐Chatterjee, Asim Saha, Kenneth A. Foon & Sunil K. Chatterjee. (2008) Carcinoembryonic Antigen Transgenic Mouse Models for Immunotherapy and Development of Cancer Vaccines. Current Protocols in Immunology 80:1.
Crossref
Crossref
Kartik Mohanty, Asim Saha, Smarajit Pal, Palash Mallick, Sunil K. Chatterjee, Kenneth A. Foon & Malaya Bhattacharya-Chatterjee. (2006) Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu. Breast Cancer Research and Treatment 104:1, pages 1-11.
Crossref
Crossref
A López-Díaz de Cerio, N Zabalegui, M Rodríguez-Calvillo, S Inogés & M Bendandi. (2007) Anti-idiotype antibodies in cancer treatment. Oncogene 26:25, pages 3594-3602.
Crossref
Crossref
Asim Saha, Sunil K. Chatterjee, Kenneth A. Foon, Esteban Celis & Malaya Bhattacharya-Chatterjee. (2007) Therapy of Established Tumors in a Novel Murine Model Transgenic for Human Carcinoembryonic Antigen and HLA-A2 with a Combination of Anti-idiotype Vaccine and CTL Peptides of Carcinoembryonic Antigen. Cancer Research 67:6, pages 2881-2892.
Crossref
Crossref
Rosalia Rabinovsky, Jonathan W. Uhr, Ellen S. Vitetta & Eitan Yefenof. 2007.
189
202
.
Li Yan & Zhenping Zhu. (2006) Development of antibody-based therapeutics for oncology indications. Drug Development Research 67:9, pages 699-728.
Crossref
Crossref
Asim Saha, Sunil K. Chatterjee, Kenneth A. Foon & Malaya Bhattacharya-Chatterjee. (2006) Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen. Immunology 0:0, pages 060526021554001-???.
Crossref
Crossref
G. Egri & A. Takáts. (2006) Monoclonal antibodies in the treatment of lung cancer. European Journal of Surgical Oncology (EJSO) 32:4, pages 385-394.
Crossref
Crossref
Yong-juan Xia, Wei-hong Wen, Wei-quan Huang & Bao-cheng Huang. (2005) Development of a phage displayed disulfide-stabilized Fv fragment vaccine against Vibrio anguillarum. Vaccine 23:24, pages 3174-3180.
Crossref
Crossref
Wei Luo, Jeff Chi-feng Hsu, Thomas Kieber-Emmons, Xinhui Wang & Soldano Ferrone. 2005.
769
787
.
Lorin K. Roskos, Sirid-Aimée Kellermann & Kenneth A. Foon. 2005. Measuring Immunity. Measuring Immunity
172
186
.
A Rossi, P Maione, G Colantuoni, C Guerriero & C. Gridelli. (2004) The role of new targeted therapies in small-cell lung cancer. Critical Reviews in Oncology/Hematology 51:1, pages 45-53.
Crossref
Crossref
Paul A. BunnJr.Jr., Frances A. Shepherd, Alan Sandler, Thierry Le Chevalier, Chandra P. Belani, Paris A. Kosmidis, Giorgio V. Scagliotti & Giuseppe Giaccone. (2003) Ongoing and future trials of biologic therapies in lung cancer. Lung Cancer 41, pages 175-186.
Crossref
Crossref
Gina Cunto-Amesty, Behjatolah Monzavi-Karbassi, Ping Luo, Fariba Jousheghany & Thomas Kieber-Emmons. (2003) Strategies in cancer vaccines development. International Journal for Parasitology 33:5-6, pages 597-613.
Crossref
Crossref